Results 11 to 20 of about 9,902,006 (336)
Th17-associated cytokine gene hypomethylation reflects epigenetic dysregulation in graves' disease. [PDF]
Front ImmunolJiang Y +7 more
europepmc +3 more sources
Frontiers in Public Health, 2021 Background: Mounting evidence has revealed the interrelationship between thyroid and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to explain the thyroid dysfunction and autoimmune thyroid disorders observed after coronavirus disease 2019 (
D. Lui +5 more
semanticscholar +1 more source
Graves-Basedow disease and potential risk factors [PDF]
Vojnosanitetski Pregled, 2008 Background/Aim. Graves-Basedow disease is a common multifactorial genetic syndrome, which is determined by several genes and environmental factors. The aim of the present study was to investigate the presence of risk factors for developing Graves-Basedow
Živanović Dušica +3 more
doaj +1 more source
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
Endocrine, 2021 Coronavirus disease 2019 (COVID-19) advances to affect every part of the globe and remains a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown to affect many organs and organ systems including the thyroid
A. K. Murugan, A. Alzahrani
semanticscholar +1 more source
Updates in the Management of Graves Disease in Children
The Ewha Medical Journal, 2023 Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years.
Yun Jeong Lee
doaj +1 more source
Graves’ disease: moving forwards
Archives of Disease in Childhood, 2022 Graves’ disease is a rare disorder that continues to present clinicians and families with a series of challenges. There are no new established treatments for children or adolescents, but the outcomes of recent clinical trials and meta-analyses have ...
L. Lane, Claire L Wood, T. Cheetham
semanticscholar +1 more source
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
Frontiers in Cellular and Infection Microbiology, 2021 Graves‘ disease (GD) is a clinical syndrome with an enlarged and overactive thyroid gland, an accelerated heart rate, Graves’ orbitopathy (GO), and pretibial myxedema (PTM). GO is the most common extrathyroidal complication of GD. GD/GO has a significant
Jueyu Hou +3 more
semanticscholar +1 more source
Graves’ disease and Graves’ orbitopathy following COVID-19
Journal of Endocrinological Investigation, 2021 Upon genetic predisposition, Graves’ disease (GD) is believed to be triggered by nongenetic factors, including infections [1]. The immune system plays a role in Coronavirus disease 2019 (COVID-19), being involved in its clinical course and outcome [2 ...
G. Lanzolla, C. Marcocci, M. Marinò
semanticscholar +1 more source
Minimal change disease associated with Graves’ disease and methimazole use
Revista Colombiana de Nefrología, 2022 Introduction. Graves' disease causes kidney injury through multiple mechanisms, including the treatment for this condition. Nephrotic syndrome due to minimal change disease (MCD) is an unusual form of such kidney injury; the association between ...
Andrés Fernando Rodríguez-Gutiérrez +1 more
doaj +1 more source
Antithyroid Drug Treatment in Graves’ Disease [PDF]
Endocrinology and Metabolism, 2021 Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence
Jae Hoon Chung
doaj +1 more source